World-class research laboratories & facilities
Did you know Sagentia owns 100,000 sq ft of dedicated research and development facilities? This R&D real estate...
Could CRISPR Diagnostics Provide a Valuable Weapon in the Fight against Pandemic Flu?
The new diagnostic assay format could provide a means of performing low-cost tests for particular strains of flu at the...
Medical devices, connectivity and avoiding innovation deadlock
Paulo Pinheiro, head of electronics, software and systems at Sagentia writes about the complex...
Medical device software development needs ‘risk compass’ for the digital age
The complex relationship between opportunity and risk in the connected world poses unprecedented challenges for medical...
Science Group is attending J.P. Morgan Healthcare 2020
The healthcare sector is a major focus for Science Group (AIM:SAG) a leading global, science-led advisory and product...
Assessing the options for companies setting challenging goals for plastic reduction
In a move to help tackle the problems of plastic reduction, many companies have set themselves ambitious goals for the...
Conventional plastics and bioplastics: How can we move from the former to the latter
Plastic products are ubiquitous due to their particular material properties – properties that scientists and...
Understanding the materials science of plastics to address end of life challenges
Non-biodegradable plastics build up in landfill or the natural environment as we produce and dispose of them many...
Reimagine products to ease plastic pollution
Rethinking the way personal care products are presented could reduce the amount of plastic waste associated with the...
The changing surgical landscape
Tighter regulatory scrutiny coupled with healthcare’s emphasis on improved outcomes has put pressure on medtech...
